{"id":1320008,"date":"2026-11-18T00:25:14","date_gmt":"2026-11-18T00:25:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/1320008\/"},"modified":"2026-11-18T00:25:14","modified_gmt":"2026-11-18T00:25:14","slug":"integrated-qtl-mapping-and-crispr-screening-in-pooled-ipsc-derived-microglia-reveals-genetic-drivers-of-neurodegenerative-risk","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/1320008\/","title":{"rendered":"Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk"},"content":{"rendered":"<p>Full methods, including software versions, are available in the <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">Supplementary Note<\/a>. Data and code are publicly available as described in the data and code availability statements.<\/p>\n<p>Human iPSC maintenance<\/p>\n<p>Our research complies with all appropriate ethical regulations. Human iPSCs were derived as part of previous projects with informed consent from all participants, donors and\/or their legal guardian(s). A total of 261 human iPSC lines from 254 European donors were obtained from the Sanger HipSci project (<a href=\"https:\/\/www.hipsci.org\/\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.hipsci.org<\/a>; Cambridgeshire 1 NRES REC Reference 09\/H0304\/77, HMDMC 14\/013), the Cardiff IPMAR project (Wales REC 3 Reference 12\/WA\/0052)<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 19\" title=\"Maguire, E. et al. Modeling common Alzheimer&#x2019;s disease with high and low polygenic risk in human iPSC: a large-scale research resource. Stem Cell Rep. 20, 102570 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR19\" id=\"ref-link-section-d41917359e2914\" rel=\"nofollow noopener\" target=\"_blank\">19<\/a> or commercially from Bioneer (TREM2 KO (BIONi010-C-17) and isogenic control (BIONi010-C)). All lines tested negative for mycoplasma and were characterized for pluripotency through stem cell marker expression, RNA-seq and\/or germ layer differentiation. Genomes were analyzed by single nucleotide polymorphism (SNP) arrays, exome and\/or WGS for chromosomal abnormalities and copy number variation and to validate identity. For a list of lines used and location of available datasets and certificates of analysis, see Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">1<\/a>.<\/p>\n<p>Cells were vitronectin-maintained in E8\/10% CloneR at 60\u201385% confluence. Before final pooling, 6\u201312 lines were seeded into mini-pools at 40,000 cells per cm2, passaged once and frozen after 3\u2009days.<\/p>\n<p>iPSC pooling and microglial differentiation<\/p>\n<p>Microglia were differentiated through embryoid bodies<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 20\" title=\"Washer, S. J. et al. Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia. Sci. Rep. 12, 19454 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR20\" id=\"ref-link-section-d41917359e2937\" rel=\"nofollow noopener\" target=\"_blank\">20<\/a>. Each pool contained between 16 and 72 donors. On day\u20099, 42 embryoid bodies were transferred to one T75 flask and differentiated into precursors. On days\u200928\u2013109, the precursors were collected for a 14-day microglial differentiation. Cell suspensions were seeded in ITMG medium at 500,000 cells per 6-well plate (Greiner Bio-One, 657160) for scRNA-seq, 3,906,250 cells per T75 flask (Greiner Bio-One, 658170) for migration or 1,126,400 cells per 6-well plate for phagocytosis assays. Media was topped up to double the volume on day\u20093 or 4 post-plating, and subsequent half-media changes were performed on day\u20097 and day\u200910 or 11.<\/p>\n<p>On day\u200911 of the microglial differentiation, cells were treated for 72\u2009h with 20\u2009ng\u2009ml\u22121 IFN\u03b3 or 100\u2009ng\u2009ml\u22121 LPS.<\/p>\n<p>iMac differentiation<\/p>\n<p>The floating precursors were collected for a 7-day iMac differentiation<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 72\" title=\"van Wilgenburg, B., Browne, C., Vowles, J. &amp; Cowley, S. A. Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS ONE 8, e71098 (2013).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR72\" id=\"ref-link-section-d41917359e2956\" rel=\"nofollow noopener\" target=\"_blank\">72<\/a> in iMac media.<\/p>\n<p>Sample preparation for scRNA-seq<\/p>\n<p>Day-14 iMGLs were dissociated at 37\u2009\u00b0C for \u226430\u2009min with 5\u2009mM EDTA and 4\u2009mg\u2009ml\u22121 lidocaine, quenched in 0.04% BSA\/DPBS, strained and counted. Chromium Next GEM 5\u2032 v2 and 5\u2032 HT v2 lanes received 17,400 and 115,405 viable cells, respectively, and followed manufacturer processing. Quality-controlled libraries were HiSeq\/NovaSeq-sequenced at \u226520,000 reads per cell.<\/p>\n<p>Migration assay<\/p>\n<p>Each 6-well transwell insert received 825,000 day-14 iMGLs in 2.7\u2009ml ITMG. After 15\u2009min, 3.168\u2009ml ITMG with or without 3\u2009nM C5a was added to the lower chamber of the insert. After 6\u2009h, sister wells were fixed in 4% paraformaldehyde, and DNA from each membrane surface plus wash pellet was Puregene-extracted.<\/p>\n<p>NucBlue-stained inserts were imaged before and after removing upper-surface cells. Cellpose v.2.0.5 (&#8211;diameter 5 &#8211;flow_threshold 0 &#8211;cellprob_threshold -8) was used to count all nuclei, and CellProfiler v.4.2.1 was used to count migrated nuclei (threshold 0.015\u20131.0). Migration was calculated as the ratio of migrated nuclei to all nuclei, and chemotaxis was defined as the C5a+ minus C5a\u2212 ratio.<\/p>\n<p>Dual color phagocytosis assay<\/p>\n<p>The SH-SY5Y mCherry-eGFP pmChGIP F4 clone was generated and cultured as previously described<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 20\" title=\"Washer, S. J. et al. Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia. Sci. Rep. 12, 19454 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR20\" id=\"ref-link-section-d41917359e2994\" rel=\"nofollow noopener\" target=\"_blank\">20<\/a>. Precursors (1,126,400 per 6-well plate) were differentiated for 14\u2009days and incubated with fixed SH-SY5Y cargo at a 2:1 cargo:iMGL ratio for 2\u2009h. Washed cells were detached, fixed in 4% paraformaldehyde and flow-sorted on a Mo-Flo XDP.<\/p>\n<p>Genomic DNA library prep for phenotypic assays<\/p>\n<p>DNA from migration and phagocytosis assays was quantified using a Qubit fluorometer. NEBNext Ultra II FS libraries with Dual Index Primer Set 1 were quality-controlled by Qubit, BioAnalyser or TapeStation and\/or KAPA qPCR, multiplexed and sequenced on an Illumina NovaSeq 6000.<\/p>\n<p>Cloning of Cas9-guide all-in-one vector<\/p>\n<p>Three guide pairs per target and intergenic controls were array-cloned into an all-in-one vector. Sequences are listed in Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">16<\/a>, and the library can be made available upon request.<\/p>\n<p>Primers containing the 5\u2032 or 3\u2032 guide were used to amplify the sgRNA backbone-tRNA region by PCR with Q5 High-Fidelity 2X Master Mix in an arrayed format to generate the dgRNA cassette<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 62\" title=\"Burgold, T. et al. A next-generation dual guide CRISPR system for genetic interaction library screening. Nat. Commun. 17, 561 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR62\" id=\"ref-link-section-d41917359e3020\" rel=\"nofollow noopener\" target=\"_blank\">62<\/a>. Purified PCR products were cloned by Gibson assembly into BsmBI-v2-digested pLentiCRISPR v3.0 and transformed into DH5-\u03b1 cells. Colonies were picked and verified by Sanger sequencing. Arrayed clones were pooled and expanded in electrocompetent cells. MiSeq verification of guide distribution was performed after nested PCR with KAPA HiFi HotStart ReadyMix with 12 cycles of 98\u2009\u00b0C for 20\u2009s, 60\u2009\u00b0C for 15\u2009s and 72\u2009\u00b0C for 15\u2009s. PCR1 was column-purified and 1\/100 of the purified product was used as template for PCR2, with 14 cycles of 98\u2009\u00b0C for 20\u2009s, 70\u2009\u00b0C for 15\u2009s and 72\u2009\u00b0C for 15\u2009s.<\/p>\n<p>Production of lentiviral particles<\/p>\n<p>Lenti-X HEK293T cells (14\u2009\u00d7\u2009106 cells) at ~70% confluence were transfected with 7.5\u2009\u03bcg pSIV3+ or library, 18.5\u2009\u03bcg psPAX2 and 4\u2009\u03bcg pMD2.G using Lipofectamine LTX. Virus collected at 48\u2009h and 72\u2009h was centrifuged, filtered (0.45\u2009\u03bcm), concentrated at 20,000g for 3\u2009h at 4\u2009\u00b0C, resuspended in 1.5% BSA\/DPBS and frozen at \u221280\u2009\u00b0C following previously published methods<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 73\" title=\"Washer, S. J., Navarro-Guerrero, E., Cowley, S. A., Ebner, D. V. &amp; Bassett, A. R. Protocol for pooled FACS-based CRISPR knockout screening in human iPSC-derived microglia. STAR Protoc. 6, 104111 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR73\" id=\"ref-link-section-d41917359e3037\" rel=\"nofollow noopener\" target=\"_blank\">73<\/a>.<\/p>\n<p>Total protein extraction and western blotting<\/p>\n<p>Day-14 cells were lysed in RIPA buffer. BCA-quantified protein (10\u201340\u2009\u03bcg) was reduced, boiled and run on 4\u201315% Mini-PROTEAN TGX gels at 100\u2009V for 75\u2009min, then transferred to PVDF under the same settings. Blocked membranes received primary antibodies overnight at 4\u2009\u00b0C, followed by HRP-conjugated secondary antibodies for 1\u2009h before chemiluminescent imaging. Densitometry values were normalized to housekeeping and untreated controls to determine \u2018relative protein expression (to control)\u2019.<\/p>\n<p>CRISPR KO screening for phagocytosis<\/p>\n<p>KOLF2.1S human iPSCs were differentiated to iMGLs as described above. The library contained 783 dual-guide all-in-one CRISPR vectors targeting 250 prioritized AD GWAS genes and 30 intergenic controls (\u2018NeuroKO\u2019)<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 54, 412&#x2013;436 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR7\" id=\"ref-link-section-d41917359e3058\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 14\" title=\"Schwartzentruber, J. et al. Molecular and functional variation in iPSC-derived sensory neurons. Nat. Genet. 50, 54&#x2013;61 (2018).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR14\" id=\"ref-link-section-d41917359e3061\" rel=\"nofollow noopener\" target=\"_blank\">14<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 52\" title=\"Buniello, A. et al. Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Res. 53, D1467&#x2013;D1475 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR52\" id=\"ref-link-section-d41917359e3064\" rel=\"nofollow noopener\" target=\"_blank\">52<\/a>. The gRNA pairs were designed using anchor guides chosen from MinLib<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 74\" title=\"Gon&#xE7;alves, E. et al. Minimal genome-wide human CRISPR&#x2013;Cas9 library. Genome Biol. 22, 40 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR74\" id=\"ref-link-section-d41917359e3068\" rel=\"nofollow noopener\" target=\"_blank\">74<\/a> and paired with guides targeting the same exon using a tRNA-based dual-guide system<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 62\" title=\"Burgold, T. et al. A next-generation dual guide CRISPR system for genetic interaction library screening. Nat. Commun. 17, 561 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR62\" id=\"ref-link-section-d41917359e3072\" rel=\"nofollow noopener\" target=\"_blank\">62<\/a>. Precursors were transduced at a multiplicity of infection between 1.2 and 1.5 along with a viral accessory protein (VPX) to improve transduction efficiency in this model<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 75\" title=\"Navarro-Guerrero, E. et al. Genome-wide CRISPR\/Cas9-knockout in human induced pluripotent stem cell (iPSC)-derived macrophages. Sci. Rep. 11, 4245 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR75\" id=\"ref-link-section-d41917359e3076\" rel=\"nofollow noopener\" target=\"_blank\">75<\/a>. We performed three biological replicates of the screen.<\/p>\n<p>After terminal differentiation to iMGL for 14\u2009days, iMGLs were incubated with pmChGIP SH-SY5Y for 6\u2009h. Non-phagocytosed cargo was washed, iMGLs lifted and fixed with 2% paraformaldehyde before sorting on the mCherry signal into four bins: the top 20%, 55\u201375% (upper middle), 25\u201345% (lower middle) and bottom 20%. dgRNA sequences were amplified and indexed by PCR and sequenced by Illumina NovaSeq. Following deconvolution, dgRNA sequences were quantified by MAGeCK<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 76\" title=\"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR76\" id=\"ref-link-section-d41917359e3083\" rel=\"nofollow noopener\" target=\"_blank\">76<\/a>. Mapping efficiency and guide representation, assessed using the Gini index, were examined with MAGeCKFlute<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 77\" title=\"Wang, B. et al. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. Nat. Protoc. 14, 756&#x2013;780 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR77\" id=\"ref-link-section-d41917359e3087\" rel=\"nofollow noopener\" target=\"_blank\">77<\/a> to confirm data quality, and are shown in Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">23<\/a>. Following this step, the guide overrepresentation was calculated between the bottom 20% and top 20% populations, representing the lowest phagocytosing and highest phagocytosing iMGLs. Full methodology has been previously published<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 73\" title=\"Washer, S. J., Navarro-Guerrero, E., Cowley, S. A., Ebner, D. V. &amp; Bassett, A. R. Protocol for pooled FACS-based CRISPR knockout screening in human iPSC-derived microglia. STAR Protoc. 6, 104111 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR73\" id=\"ref-link-section-d41917359e3094\" rel=\"nofollow noopener\" target=\"_blank\">73<\/a>.<\/p>\n<p>Arrayed lentiviral screening<\/p>\n<p>AOWH_2, HEGP_3 and KOLF2.1S lines from the HipSci repository (<a href=\"http:\/\/www.hipsci.org\" rel=\"nofollow noopener\" target=\"_blank\">www.hipsci.org<\/a>) were used for all CRISPR screening validation. Three TREM2 and three intergenic sgRNAs were cloned, produced, resazurin-titrated and pooled. Day\u200936, 40 and 46 precursors received 4\u2009\u03bcg\u2009ml\u22121 polybrene under wild-type, VPX control, TREM2-virus or intergenic-virus conditions. The medium was replaced after 24\u2009h, and 1\u2009\u03bcg\u2009ml\u22121 puromycin was added on days\u20093 or 4, with half-changes on days\u20097 and 10. Day-14 TREM2\/vinculin western blotting and 6\u2009h pmChGIP SH-SY5Y flow cytometry were used to assess knockdown and phagocytosis, respectively.<\/p>\n<p>TREM2 ASO knockdown<\/p>\n<p>An overview of the ASO experiments is provided in Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">22<\/a>. TREM2-171, TREM2-192, Scramble 1 and Scramble 2 ASO sequences<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 71\" title=\"Vandermeulen, L. et al. Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer&#x2019;s disease. Mol. Neurodegener. 19, 37 (2024).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR71\" id=\"ref-link-section-d41917359e3128\" rel=\"nofollow noopener\" target=\"_blank\">71<\/a> (Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">16<\/a>) were applied to KOLF2.1S precursors on day\u20097 at triplicate doses from 20\u2009\u03bcM to 76.3\u2009pM. Protein was collected on day\u200914. Half-maximal inhibitory concentration (IC50) and 90% inhibitory concentration (IC90) values were calculated in R using the drm() function from the drc package (v.3.0-1)<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 78\" title=\"Ritz, C., Jensen, S. M., Gerhard, D. &amp; Streibig, J. C. Dose&#x2013;Response Analysis Using R (CRC Press, 2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR78\" id=\"ref-link-section-d41917359e3140\" rel=\"nofollow noopener\" target=\"_blank\">78<\/a> (Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">22<\/a>). For validation experiments, the above protocol was repeated at the respective IC50 and IC90 doses for TREM2-171 and TREM2-192, with the scramble controls matching the respective IC doses for each TREM2-targeting ASO.<\/p>\n<p>AOWH_2, HEGP_3 and KOLF2.1S were used as follows. Precursors from days\u200936, 40 and 46 were plated at 4.84\u2009\u00d7\u2009105 cells per ml in 48-well plates. ASO was added on day\u20097, with half-medium changes on days\u20093 or 4 and day\u200910, and assays on day\u200914. TREM2\/vinculin western blotting and 6\u2009h pmChGIP SH-SY5Y flow cytometry were used to measure protein and phagocytosis relative to vehicle.<\/p>\n<p>Genotype imputation and quality control<\/p>\n<p>Genotyping array files from the HipSci (<a href=\"http:\/\/www.hipsci.org\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.hipsci.org<\/a>) and IPMAR projects<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 19\" title=\"Maguire, E. et al. Modeling common Alzheimer&#x2019;s disease with high and low polygenic risk in human iPSC: a large-scale research resource. Stem Cell Rep. 20, 102570 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR19\" id=\"ref-link-section-d41917359e3171\" rel=\"nofollow noopener\" target=\"_blank\">19<\/a> were imputed using the genimpute pipeline eQTL Catalog<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 79\" title=\"Alasoo, K., Partel, L. A., Kodar, M.-E., Tambets, R. &amp; Vosa, U. eQTLGen\/eQTLGenImpute: genotype imputation pipeline for eQTLGen phase II project. GitHub &#010;                https:\/\/github.com\/eQTLGen\/eQTLGenImpute&#010;                &#010;               (2024).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR79\" id=\"ref-link-section-d41917359e3175\" rel=\"nofollow noopener\" target=\"_blank\">79<\/a>. Post-imputation quality control retained variants with imputation r2\u2009&gt;\u20090.4 and MAF\u2009&gt;\u20090.01. Sex was imputed for donors with bcftools +guess-ploidy on X chromosome region 2,781,480\u2013155,701,381.<\/p>\n<p>Donor proportion deconvolution by WGS<\/p>\n<p>We developed poodleR, an R library that uses WGS to measure each donor\u2019s proportion within each pool. It requires that donors are genotyped, and then variants are subset to those that present variation across all donors per individual pool. See the <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">Supplementary Note<\/a> for more details.<\/p>\n<p>We simulated WGS pools with known donor proportions sequenced at a variety of mean depths to estimate the performance of the method, sampling lines for each scenario 100 times. The absolute error (Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">4a<\/a>) compared real to estimated proportions. Relative error was calculated as abs((real proportion\u2009\u2212\u2009estimated proportion)\u2009\/\u2009real proportion)\u2009\u00d7\u2009100 (Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">4b<\/a>). Relative accuracy was measured as 100\u2009\u2212\u2009relative error.<\/p>\n<p>Estimation of cellular phenotypes<\/p>\n<p>WGS from 243 donor iPSC lines (19\u201324 per pool) for 14\u201315 pooled experiments was generated for the cellular phenotypes (differentiation efficiency, migration or phagocytosis). poodleR donor proportions (Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">6<\/a>) were corrected by the nearest simulated absolute error. For the differentiation efficiency phenotype, log-fractions were calculated per line, pool and replicate as log(proportion at later stage\u2009\/\u2009proportion at earlier stage) for macrophage precursors versus iPSCs, aged (day\u200946\u2013109) versus young (day\u200928\u201336) macrophage precursors and microglia versus macrophage precursors (Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>) and then scaled per replicate.<\/p>\n<p>For the phagocytosis phenotype, log-fractions were calculated per line, pool and replicate as log(proportion mCherry+\u2009\/\u2009proportion mCherry\u2212), then scaled per replicate. For the migration phenotype, log-fractions were calculated as log(proportion bottom side of transwell\u2009\/\u2009proportion top side of transwell) per line, pool and replicate in the C5a+ and C5a\u2212 conditions separately; then the C5a+ fractions were normalized to their C5a\u2212 fractions and scaled per replicate.<\/p>\n<p>Association of cell line features with differentiation efficiency<\/p>\n<p>We tested covariate effects on differentiation efficiency across iPSC-to-precursor, young-to-aged precursor and precursor-to-iMGL transitions using linear mixed models. Models included PluriTest pluripotency and novelty scores<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 32\" title=\"M&#xFC;ller, F.-J. et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 8, 315&#x2013;317 (2011).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR32\" id=\"ref-link-section-d41917359e3242\" rel=\"nofollow noopener\" target=\"_blank\">32<\/a>, sex, pool, number of donors per pool and donors as a random intercept. To test for the donor effect, it was set to a fixed effect and pool to a random intercept. Precursor age and treatment were also tested for iMGL differentiation. Significance was assessed using drop1(test\u2009=\u2009\u201cChisq\u201d) in R. Analyses included lines present in \u22652 pools (n\u2009=\u200973\u201389). Given that the differentiation score partially depends on that of the adjacent stage, multiple testing correction was not applied. IPMAR versus HipSci and AD versus healthy effects were tested separately by t-test because they were confounded with pool (n\u2009=\u2009220\u2013241).<\/p>\n<p>Correlation between iPSC gene expression profiles and differentiation from iPSC to precursors<\/p>\n<p>Bulk iPSC RNA-seq data from a previous publication<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 80\" title=\"Cuomo, A. S. E. et al. Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression. Nat. Commun. 11, 810 (2020).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR80\" id=\"ref-link-section-d41917359e3263\" rel=\"nofollow noopener\" target=\"_blank\">80<\/a> that overlapped with the lines included in this study were correlated with precursor differentiation efficiency. Scores were adjusted for sex and PluriTest measures. Pearson correlations were tested using 1,000 permutations of residualized scores (Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">17<\/a>). Significant genes were analyzed with gProfiler<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 81\" title=\"Kolberg, L. et al. g:Profiler&#x2014;interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 51, W207&#x2013;W212 (2023).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR81\" id=\"ref-link-section-d41917359e3270\" rel=\"nofollow noopener\" target=\"_blank\">81<\/a>, using Bonferroni correction.<\/p>\n<p>Correlation between iMGL and brain cell line differentiation<\/p>\n<p>Using a previously published<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Jerber, J. et al. Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nat. Genet. 53, 304&#x2013;312 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR17\" id=\"ref-link-section-d41917359e3282\" rel=\"nofollow noopener\" target=\"_blank\">17<\/a> dataset, we derived a comparable metric of differentiation efficiency by calculating within-pool scaled log(day\u200952\/day\u200911) donor proportions from their untreated cells (using their Supplementary Table 2). Proliferation was measured across all differentiated cells and within dopaminergic\/serotonergic-like neurons. Their differentiation efficiency metric was centered and unit-scaled; Pearson r and P\u2009values were reported for all three comparisons.<\/p>\n<p>Functional variant effect annotation of whole-exome sequencing<\/p>\n<p>Whole-exome sequencing files from 226 lines were PASS-filtered as previously described<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 28\" title=\"Rouhani, F. J. et al. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nat. Genet. 54, 1406&#x2013;1416 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR28\" id=\"ref-link-section-d41917359e3300\" rel=\"nofollow noopener\" target=\"_blank\">28<\/a>, and functional variant effects were annotated using the variant effect predictor<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 82\" title=\"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR82\" id=\"ref-link-section-d41917359e3304\" rel=\"nofollow noopener\" target=\"_blank\">82<\/a>. Deleterious variants (69,223 variants across 16,348 genes) comprised frameshift, stop-gained, transcript ablation, splice acceptor or splice donor, or those annotated as missense, start-lost and protein-altering, which had CADD Phred scores over 15. All other missense variants were considered missense non-deleterious (\u2018missense\u2019, 62,022 variants across 15,523 genes).<\/p>\n<p>Test of deleterious and missense variant effects on cellular phenotypes<\/p>\n<p>Gene-level missense and deleterious associations with line-level mean scaled phenotypes were tested using the sequence kernel association optimal test (SKAT-O)<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 83\" title=\"Lee, S., Wu, M. C. &amp; Lin, X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13, 762&#x2013;775 (2012).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR83\" id=\"ref-link-section-d41917359e3316\" rel=\"nofollow noopener\" target=\"_blank\">83<\/a>, with skat<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 84\" title=\"Lee, S. &amp; Zhao, Z. SKAT: SNP-set (sequence) kernel association test, v.2.2.5 &#010;                https:\/\/CRAN.R-project.org\/package=SKAT&#010;                &#010;               (2023).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR84\" id=\"ref-link-section-d41917359e3320\" rel=\"nofollow noopener\" target=\"_blank\">84<\/a> in R. A total of 194, 178 and 197 lines were tested for iPSC-to-precursor, young-to-aged precursor and precursor-to-iMGL, respectively. Empirical P\u2009values used 1,000 null-residual bootstraps adjusted for sex, mean minimum donor proportion, genotype PCs one and two and, for phagocytosis or migration, differentiation efficiency of precursor-to-iMGL. For significant genes, variants were aggregated as previously described<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 12\" title=\"Puigdevall, P., Jerber, J., Danecek, P., Castellano, S. &amp; Kilpinen, H. Somatic mutations alter the differentiation outcomes of iPSC-derived neurons. Cell Genom. 3, 100280 (2023).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR12\" id=\"ref-link-section-d41917359e3327\" rel=\"nofollow noopener\" target=\"_blank\">12<\/a>, and burden betas were estimated by linear mixed model regression using lmerTest<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 85\" title=\"Kuznetsova, A., Brockhoff, P. &amp; Christensen, R. lmerTest package: tests in linear mixed effects models. J. Stat. Softw. 82, 1&#x2013;26 (2017).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR85\" id=\"ref-link-section-d41917359e3331\" rel=\"nofollow noopener\" target=\"_blank\">85<\/a> with the same covariates as for SKAT-O and including an (1|pool) term. For phagocytosis and migration, we used the following formula:<\/p>\n<p>Scaled phenotype (phagocytosis or migration)\u2009~\u2009deleterious burden\u2009+\u2009sex\u2009+\u2009minimum line proportion in replicate\u2009+\u2009scaled differentiation\u2009+\u2009genotype PC1\u2009+\u2009genotype PC2\u2009+\u2009(1|pool).<\/p>\n<p>For iPSC-to-precursor and young-to-aged precursor differentiation efficiency phenotype, we fitted the same formula without including differentiation efficiency as a covariate. For the effects on precursors-to-iMGL, the test was performed in the same way, including an additional (1|treatment) term. Bonferroni-significant genes were aggregated by beta direction and retested. Global burden was tested by aggregating all genes.<\/p>\n<p>Area under the curve was calculated by building a binary classification of \u2018dropouts\u2019 or \u2018takeovers\u2019 for lines with a differentiation efficiency of &gt;2\u2009s.d. below or above the mean, respectively, and then testing the aggregated burden of deleterious variants in significant genes in the relevant direction as predictors.<\/p>\n<p>Genes showing significant differentiation effects, previously identified using SKAT-O, were tested for enrichment among DepMap essential genes and macrophage survival genes from a previous publication<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 31\" title=\"Covarrubias, S. et al. High-throughput CRISPR screening identifies genes involved in macrophage viability and inflammatory pathways. Cell Rep. 33, 108541 (2020).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR31\" id=\"ref-link-section-d41917359e3348\" rel=\"nofollow noopener\" target=\"_blank\">31<\/a> (Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">18<\/a>), using Fisher\u2019s exact test.<\/p>\n<p>scRNA-seq processing and line identity deconvolution<\/p>\n<p>FASTQ files were processed with 10x Genomics Cell Ranger<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 86\" title=\"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR86\" id=\"ref-link-section-d41917359e3364\" rel=\"nofollow noopener\" target=\"_blank\">86<\/a> using default parameters. scRNA-seq deconvolution was performed with Vireo<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 87\" title=\"Huang, Y., McCarthy, D. J. &amp; Stegle, O. Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference. Genome Biol. 20, 273 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR87\" id=\"ref-link-section-d41917359e3368\" rel=\"nofollow noopener\" target=\"_blank\">87<\/a> and cellSNP-lite<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 88\" title=\"Huang, X. &amp; Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics 37, 4569&#x2013;4571 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR88\" id=\"ref-link-section-d41917359e3372\" rel=\"nofollow noopener\" target=\"_blank\">88<\/a> using default parameters.<\/p>\n<p>A total of 3,404,020 cells were processed in Seurat (v.5.0.3)<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 89\" title=\"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293&#x2013;304 (2024).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR89\" id=\"ref-link-section-d41917359e3379\" rel=\"nofollow noopener\" target=\"_blank\">89<\/a> (Supplementary Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM4\" rel=\"nofollow noopener\" target=\"_blank\">19<\/a>), filtering out low-quality cells (those with &gt;10% mitochondrial genes, that presented a number of unique molecular identifier counts under the 5th percentile, doublets and cells with unassigned line identity; Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">1a<\/a>); 2,341,497 remained across all pools and treatments. Each pool\u2013treatment combination was log-normalized, and the 2,000 most variable genes were selected for integration using a 5,000-cell \u2018sketched\u2019 subset generated with SketchData(), which samples without replacement while retaining rare cell types. On this subset, principal component analysis, shared nearest-neighbor construction, Louvain clustering and uniform manifold approximation and projection were performed. Pools were integrated using Harmony, and remaining cells were projected onto the integrated manifold.<\/p>\n<p>Integrated uniform manifold approximation and projection plots were annotated using marker genes and previously published differential expression gene sets<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 21\" title=\"Mancuso, R. et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer&#x2019;s disease-related amyloid-&#x3B2; pathology. Nat. Neurosci. 27, 886&#x2013;900 (2024).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR21\" id=\"ref-link-section-d41917359e3392\" rel=\"nofollow noopener\" target=\"_blank\">21<\/a> using Seurat\u2019s AddModuleScore(). In parallel, each treatment was mapped to the integrated PCA reference from that publication<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 21\" title=\"Mancuso, R. et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer&#x2019;s disease-related amyloid-&#x3B2; pathology. Nat. Neurosci. 27, 886&#x2013;900 (2024).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR21\" id=\"ref-link-section-d41917359e3396\" rel=\"nofollow noopener\" target=\"_blank\">21<\/a> using Seurat\u2019s anchor-based reference mapping workflow. Transfer anchors were identified using shared genes and the first 30 PCs, labels were transferred with TransferData() and query cells were projected into the reference embedding using MapQuery(). Visualizations were generated with SCpubr<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 90\" title=\"Blanco-Carmona, E. &amp; Kool, M. SCpubr: a user-friendly R-package for generating publication-ready visualizations of single-cell transcriptome analyses. Bioinform. Adv. 1, vbag151 (2026).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR90\" id=\"ref-link-section-d41917359e3400\" rel=\"nofollow noopener\" target=\"_blank\">90<\/a> and scCustomize<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 91\" title=\"Marsh, S. samuel-marsh\/scCustomize: version 0.6.0. Zenodo &#010;                https:\/\/doi.org\/10.5281\/zenodo.5706431&#010;                &#010;               (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR91\" id=\"ref-link-section-d41917359e3404\" rel=\"nofollow noopener\" target=\"_blank\">91<\/a>. Overrepresentation of donors within each cluster was tested with a Wilcoxon rank-sum test.<\/p>\n<p>PRS calculations<\/p>\n<p>PRS were calculated with PRSice-2 (ref. <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 92\" title=\"Choi, S. W. &amp; O&#x2019;Reilly, P. F. PRSice-2: polygenic risk score software for biobank-scale data. Gigascience 8, giz082 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR92\" id=\"ref-link-section-d41917359e3416\" rel=\"nofollow noopener\" target=\"_blank\">92<\/a>). We first excluded the APOE regions and then used the remaining regions of the AD GWAS summary statistics (from ref. <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 54, 412&#x2013;436 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR7\" id=\"ref-link-section-d41917359e3420\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>), with LD from the subset of European-ancestry individuals from the 1000 Genomes Project (1000G EUR). As a non-default parameter, we set the P\u2009value threshold to 0.1. We then calculated the PRS for the 1000G EUR cohort for the variants shared with our sample. We adjusted the raw scores for five genotype PCs for both datasets, and scaled the HipSci and IPMAR line scores to those of the 1000G EUR cohort. We then added the scores for the APOE alleles with values B(APOE \u03b52)\u2009=\u2009\u22120.47, B(APOE \u03b53)\u2009=\u20090 and B(APOE \u03b54)\u2009=\u20091.12, as previously reported<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 93\" title=\"Leonenko, G. et al. Identifying individuals with high risk of Alzheimer&#x2019;s disease using polygenic risk scores. Nat. Commun. 12, 4506 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR93\" id=\"ref-link-section-d41917359e3427\" rel=\"nofollow noopener\" target=\"_blank\">93<\/a>, and scaled them to those of the 1000G EUR dataset. Finally, we added the scaled polygenic and APOE scores to obtain the full PRS. The distribution of the two PRS is shown in Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">12a\u2013c<\/a>.<\/p>\n<p>For microglia-specific PRS, \u00b1250\u2009kb regions around lead loci colocalizing between eQTLs and AD GWAS were selected per treatment and used as input to PRSice-2 for our 261 donors and 1000G EUR scaling data. All other scoring steps were unchanged. PRS distributions are shown in Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">12e<\/a>.<\/p>\n<p>Differential expression across treatments<\/p>\n<p>Raw unique molecular identifier counts from non-proliferative clusters were aggregated by line, pool and treatment replicate. Samples with fewer than 100 cells were excluded, leaving 194 lines, and genes were retained if they were detected at \u22651 counts per million (CPM) in at least 30% of donors (Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">2a<\/a>). Counts were transformed to log2(CPM) and analyzed with limma<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 94\" title=\"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR94\" id=\"ref-link-section-d41917359e3453\" rel=\"nofollow noopener\" target=\"_blank\">94<\/a> using voom() weights and duplicateCorrelation() to account for pool effects. The model was:<\/p>\n<p>Gene expression\u2009~\u2009treatment\u2009+\u2009donor\u2009+\u2009log10(ncells)<\/p>\n<p>Sex and age were omitted because they were confounded with donor, and age was incompletely recorded. Contrasts were tested for IFN\u03b3-treated versus untreated, LPS-treated versus untreated and IFN\u03b3-treated versus LPS-treated, with moderated t-statistics from eBayes() and Benjamini\u2013Hochberg FDR correction. The log2(FC) in expression takes the second element in the contrast as the baseline; log2(FC) was defined relative to the second contrast group. Significant genes numbered 926 downregulated and 800 upregulated for IFN\u03b3-treated versus untreated, 1,144 downregulated and 892 upregulated for LPS-treated versus untreated and 975 downregulated and 1,078 upregulated for IFN\u03b3-treated versus LPS-treated.<\/p>\n<p>Differential expression across PRS<\/p>\n<p>Counts were aggregated, filtered, transformed and adjusted for pool effects as above. Within each treatment, we fitted:<\/p>\n<p>Gene expression\u2009~\u2009PRS\u2009+\u2009sex\u2009+\u2009log10(ncells)<\/p>\n<p>Age was excluded because of incomplete records and confounding with high PRS among IPMAR donors with AD. PRS coefficients represent log2(FC) per unit increase in PRS. At FDR\u2009&lt;\u20090.05, 80 genes were downregulated and 63 upregulated in untreated cells, 24 downregulated and 32 upregulated in IFN\u03b3-treated cells, and 7 downregulated and 14 upregulated in LPS-treated cells.<\/p>\n<p>Empirical P\u2009values were obtained by permuting donor PRS values 100 times and comparing observed gene-level t-statistics with the permutation distribution.<\/p>\n<p>Differential expression across phenotypes<\/p>\n<p>Counts were aggregated and filtered as above. Replicate measurements of scaled migration and phagocytosis phenotypes were averaged, together with the minimum line proportion to account for increased variance in low-abundance lines. Analyses were performed separately by treatment using limma while accounting for pool effects:<\/p>\n<p>Gene expression\u2009~\u2009scaled phenotype\u2009+\u2009sex\u2009+\u2009min. line proportion\u2009+\u2009genotype PC1\u2009+\u2009genotype PC2.<\/p>\n<p>Genes with FDR-adjusted P\u2009&lt;\u20090.05 were considered significant. The log2(FC) represents the expression change per unit increase in the scaled phenotype.<\/p>\n<p>Enrichment analysis in differential expression and eQTL results<\/p>\n<p>Genes were ranked by treatment-specific differential expression t-statistics. Transcription factor and PROGENy pathway activities were inferred using decoupleR<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 95\" title=\"Badia-I-Mompel, P. et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform. Adv. 2, vbac016 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR95\" id=\"ref-link-section-d41917359e3529\" rel=\"nofollow noopener\" target=\"_blank\">95<\/a> with <a href=\"https:\/\/github.com\/saezlab\/CollecTRI\" rel=\"nofollow noopener\" target=\"_blank\">CollecTRI<\/a> ref. <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 96\" title=\"M&#xFC;ller-Dott, S. et al. Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities. Nucleic Acids Res. 51, 10934&#x2013;10949 (2023).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR96\" id=\"ref-link-section-d41917359e3540\" rel=\"nofollow noopener\" target=\"_blank\">96<\/a> and <a href=\"https:\/\/saezlab.github.io\/progeny\/\" rel=\"nofollow noopener\" target=\"_blank\">PROGENy<\/a> ref. <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 97\" title=\"Schubert, M. et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat. Commun. 9, 20 (2018).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR97\" id=\"ref-link-section-d41917359e3552\" rel=\"nofollow noopener\" target=\"_blank\">97<\/a>, respectively. MSigDB Hallmark pathways and candidate gene sets were tested with gene set enrichment analysis<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 98\" title=\"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545&#x2013;15550 (2005).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR98\" id=\"ref-link-section-d41917359e3556\" rel=\"nofollow noopener\" target=\"_blank\">98<\/a> using msigdbr<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 99\" title=\"Dolgalev, I. MSigDB R data frame. GitHub &#010;                https:\/\/igordot.github.io\/msigdbr&#010;                &#010;              \" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR99\" id=\"ref-link-section-d41917359e3560\" rel=\"nofollow noopener\" target=\"_blank\">99<\/a> and fgsea<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 100\" title=\"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv &#010;                https:\/\/doi.org\/10.1101\/060012&#010;                &#010;               (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR100\" id=\"ref-link-section-d41917359e3564\" rel=\"nofollow noopener\" target=\"_blank\">100<\/a>, with Bonferroni correction for gene sets and Benjamini\u2013Hochberg correction for pathways. AD, PD, MS and ALS candidate gene sets were defined from Open Targets Genetics locus-to-gene scores (globalScore of \u22650.05). eQTL eGenes were tested for protein\u2013protein interaction and Gene Ontology enrichment using STRINGdb<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 101\" title=\"Szklarczyk, D. et al. The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res. 53, D730&#x2013;D737 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR101\" id=\"ref-link-section-d41917359e3568\" rel=\"nofollow noopener\" target=\"_blank\">101<\/a>.<\/p>\n<p>Filtering genotypes and lines for eQTL and phenotype association analysis<\/p>\n<p>Genotype quality control included filtering out variants with imputation INFO\u2009&lt;\u20090.7, Hardy\u2013Weinberg equilibrium P\u2009&lt;\u200910\u22126, &gt;10% sample missingness or MAF\u2009&lt;\u20095%, leaving 6,405,518 variants. The 1000 Genomes data were filtered similarly and used for joint PCA. One line from each clone pair and four donors not clustering near European populations were excluded (Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">12d<\/a>), leaving 250 donors for downstream analyses.<\/p>\n<p>eQTL mapping<\/p>\n<p>scRNA-seq counts from non-proliferative clusters were aggregated into donor-level pseudobulks, as treatment-specific subtypes were poorly defined and eQTL detection is strongly influenced by cell number<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 25\" title=\"Soskic, B. et al. Immune disease risk variants regulate gene expression dynamics during CD4 T cell activation. Nat. Genet. 54, 817&#x2013;826 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR25\" id=\"ref-link-section-d41917359e3597\" rel=\"nofollow noopener\" target=\"_blank\">25<\/a>. Genes were retained if they were detected at \u22651 CPM in at least 30% of donors, then log-normalized and scaled. Pseudobulks with fewer than 100 cells, duplicate clones, donors without genotype data and donors without predicted European ancestry were excluded, leaving 188 donors for IFN\u03b3 and LPS and 189 untreated donors.<\/p>\n<p>cis-eQTL mapping was performed with tensorQTL<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 102\" title=\"Taylor-Weiner, A. et al. Scaling computational genomics to millions of individuals with GPUs. Genome Biol. 20, 288 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR102\" id=\"ref-link-section-d41917359e3606\" rel=\"nofollow noopener\" target=\"_blank\">102<\/a> using variants within \u00b1250\u2009kb of each transcription start site, adjusting for two genotype PCs and 5\u2013120 expression PCs. map_cis used 1,000 permutations to obtain empirical significance; eGenes with FDR\u2009&lt;\u20090.05 were retained. Expression PC numbers maximizing eGene discovery were 63, 73 and 84 for untreated, IFN\u03b3-treated and LPS-treated, respectively.<\/p>\n<p>The degree of eQTL sharing was calculated by multivariate adaptive shrinkage with mashR<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 103\" title=\"Araujo, D. S. et al. Multivariate adaptive shrinkage improves cross-population transcriptome prediction and association studies in underrepresented populations. HGG Adv. 4, 100216 (2023).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR103\" id=\"ref-link-section-d41917359e3613\" rel=\"nofollow noopener\" target=\"_blank\">103<\/a>. Tested genes and gene\u2013variant pairs were highly concordant across treatments, with pairwise Jaccard similarities of 0.93\u20130.94 (Supplementary Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM1\" rel=\"nofollow noopener\" target=\"_blank\">3b<\/a>). Lead eQTL\u2013eGene pairs were evaluated across treatments, and eQTLs were considered shared when the local false sign rate (lfsr) was &lt;0.05 and posterior effects had the same sign and differed by less than 0.5.<\/p>\n<p>GWAS of cellular phenotypes<\/p>\n<p>Genotypes and lines were filtered as for eQTL analyses. To reduce false positives from repeated measurements and low-abundance donors, samples were retained only when the smaller donor fraction was \u22651%, then scaled phenotypes were averaged across pools and replicates. For phagocytosis, 133, 137 and 140 lines remained in untreated, IFN\u03b3-treated and LPS-treated conditions; for migration, 147, 92 and 147; and for differentiation, 209, 229 and 230, respectively. Associations were tested by linear regression:<\/p>\n<p>Mean phenotype\u2009~\u2009Alternative allele dosage\u2009+\u2009sex\u2009+\u2009number of pool replicates\u2009+\u2009genotype PC1-5.<\/p>\n<p>Colocalization analysis of eQTLs and GWASs<\/p>\n<p>External AD<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 54, 412&#x2013;436 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR7\" id=\"ref-link-section-d41917359e3639\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>, PD<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 54\" title=\"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091&#x2013;1102 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR54\" id=\"ref-link-section-d41917359e3643\" rel=\"nofollow noopener\" target=\"_blank\">54<\/a>, MS<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 56\" title=\"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR56\" id=\"ref-link-section-d41917359e3647\" rel=\"nofollow noopener\" target=\"_blank\">56<\/a> and ALS<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 55\" title=\"van Rheenen, W. et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 53, 1636&#x2013;1648 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR55\" id=\"ref-link-section-d41917359e3651\" rel=\"nofollow noopener\" target=\"_blank\">55<\/a> GWASs and our eQTL datasets were subset to loci in which significant lead eQTLs (FDR\u2009&lt;\u20090.05) and GWAS variants (P\u2009&lt;\u20095\u2009\u00d7\u200910\u22128) occurred within 500\u2009kb. Colocalization was performed on \u226550 shared variants using coloc<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 104\" title=\"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR104\" id=\"ref-link-section-d41917359e3661\" rel=\"nofollow noopener\" target=\"_blank\">104<\/a> under the single causal variant assumption. Default p1 and p2 priors were used, with p12\u2009=\u20091\u2009\u00d7\u200910\u22126. Loci with PP.H4 (\u2018both traits are associated and share a single causal variant\u2019) of &gt;70% were considered colocalized.<\/p>\n<p>Locus plots were generated with locuszoomr<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 105\" title=\"Lewis, M. J. &amp; Wang, S. locuszoomr: an R package for visualizing publication-ready regional gene locus plots. Bioinform Adv. 5, vbaf006 (2025).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR105\" id=\"ref-link-section-d41917359e3670\" rel=\"nofollow noopener\" target=\"_blank\">105<\/a> using 1000 Genomes GRCh38 high-coverage LD from LDlink<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 106\" title=\"Machiela, M. J. &amp; Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555&#x2013;3557 (2015).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR106\" id=\"ref-link-section-d41917359e3674\" rel=\"nofollow noopener\" target=\"_blank\">106<\/a>. Colocalization with iMGL cellular phenotype associations was performed similarly using shared significant eQTL variants.<\/p>\n<p>Fine mapping of TREM2 AD GWAS locus<\/p>\n<p>Selected GWAS loci were fine-mapped with susieR<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 107\" title=\"Wang, G., Sarkar, A., Carbonetto, P. &amp; Stephens, M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J. R. Stat. Soc. Series B Stat. Methodol. 82, 1273&#x2013;1300 (2020).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR107\" id=\"ref-link-section-d41917359e3686\" rel=\"nofollow noopener\" target=\"_blank\">107<\/a> using harmonized summary statistics and 1000 Genomes GRCh38 high-coverage LD from LDlink<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 106\" title=\"Machiela, M. J. &amp; Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555&#x2013;3557 (2015).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR106\" id=\"ref-link-section-d41917359e3690\" rel=\"nofollow noopener\" target=\"_blank\">106<\/a>. Non-default arguments for susie_rss() were: n\u2009=\u2009aggregate number of cases and controls in GWAS; L\u2009=\u20091; coverage\u2009=\u20090.60; min_abs_corr\u2009=\u20090.0.<\/p>\n<p>Testing for enrichment in disease heritability near gene sets<\/p>\n<p>Disease heritability enrichment was tested using stratified LDSC<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 108\" title=\"Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228&#x2013;1235 (2015).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR108\" id=\"ref-link-section-d41917359e3702\" rel=\"nofollow noopener\" target=\"_blank\">108<\/a> implemented with CELLECT<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 109\" title=\"Timshel, P. N., Thompson, J. J. &amp; Pers, T. H. Genetic mapping of etiologic brain cell types for obesity. eLife 9, e55851 (2020).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR109\" id=\"ref-link-section-d41917359e3706\" rel=\"nofollow noopener\" target=\"_blank\">109<\/a>. Differential expression t-statistics were directionally separated and min\u2013max scaled from 0\u20131, with opposite-sign genes set to zero. eGenes were similarly ranked using mashR scores (\u2212log10(lfsr)\u2009\u00d7\u2009posterior mean) and scaled. CELLECT-LDSC then tested whether highly ranked genes were enriched for disease-associated heritability in each treatment.<\/p>\n<p>TWMR analysis<\/p>\n<p>TWMR<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 40\" title=\"Porcu, E. et al. Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits. Nat. Commun. 10, 3300 (2019).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR40\" id=\"ref-link-section-d41917359e3724\" rel=\"nofollow noopener\" target=\"_blank\">40<\/a> was used to estimate causal effects of gene expression on microglial phenotypes. For each treatment-specific focus eGene, we selected the lead eQTL and top colocalizing variant, expanded to associated eGenes and significant eQTLs (P\u2009&lt;\u200910\u22128), and pruned variants for LD (R2\u2009&lt;\u20090.2) and correlated eGenes (R2\u2009\u2264\u20090.4). Phenotype GWAS effects were combined with eQTL effects using:<\/p>\n<p>$$\\hat{{\\rm{\\alpha }}}={\\left({{\\rm{E}}}^{{\\prime} }{{\\rm{C}}}^{-1}{\\rm{E}}\\right)}^{-1}\\left({{\\rm{E}}}^{{\\prime} }{{\\rm{C}}}^{-1}{\\rm{G}}\\right)$$<\/p>\n<p>where E contains SNP\u2013eGene effects, G represents phenotype GWAS effects and C is the LD matrix obtained from TOPMed EUR<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 110\" title=\"Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290&#x2013;299 (2021).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR110\" id=\"ref-link-section-d41917359e3914\" rel=\"nofollow noopener\" target=\"_blank\">110<\/a> using TopLD<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 111\" title=\"Huang, L. et al. TOP-LD: a tool to explore linkage disequilibrium with TOPMed whole-genome sequence data. Am. J. Hum. Genet. 109, 1175&#x2013;1181 (2022).\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#ref-CR111\" id=\"ref-link-section-d41917359e3918\" rel=\"nofollow noopener\" target=\"_blank\">111<\/a>. Only genes with an F-statistic of &gt;10 were retained to limit weak-instrument bias.<\/p>\n<p>Association of PRS with microglial phenotype<\/p>\n<p>Full and microglia-specific PRS were tested against microglial phenotypes by linear regression after phenotype processing as done for GWAS:<\/p>\n<p>Mean phenotype\u2009~\u2009PRS\u2009+\u2009sex\u2009+\u2009number of pool replicates\u2009+\u2009average minimum donor proportion.<\/p>\n<p>PRS terms included the full score, polygenic component or APOE component. Genotype PCs were omitted because PRS had already been PC-adjusted.<\/p>\n<p>Reporting summary<\/p>\n<p>Further information on research design is available in the <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"http:\/\/www.nature.com\/articles\/s41588-026-02843-0#MOESM2\" rel=\"nofollow noopener\" target=\"_blank\">Nature Portfolio Reporting Summary<\/a> linked to this article.<\/p>\n","protected":false},"excerpt":{"rendered":"Full methods, including software versions, are available in the Supplementary Note. Data and code are publicly available as&hellip;\n","protected":false},"author":2,"featured_media":1320009,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[11],"tags":[3971,3973,3967,3970,23753,3972,3968,7189,354235,105,3969,220,9721,16,15],"class_list":["post-1320008","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-agriculture","tag-animal-genetics-and-genomics","tag-biomedicine","tag-cancer-research","tag-functional-genomics","tag-gene-function","tag-general","tag-genome-wide-association-studies","tag-genomic-analysis","tag-health","tag-human-genetics","tag-neuroscience","tag-stem-cells","tag-uk","tag-united-kingdom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/117634604978534856","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1320008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=1320008"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1320008\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/1320009"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=1320008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=1320008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=1320008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}